RecruitingPHASE1, PHASE2NCT06279741

Safety and Efficacy of MSC-EVs in the Prevention of BPD in Extremely Preterm Infants

Studying Bronchopulmonary dysplasia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
EXO Biologics S.A.
Principal Investigator
Beatrice De Vos, M.D., Ph.D.
EXO Biologics SA
Intervention
Endotracheopulmonary Instillation, Suspension(biological)
Enrollment
265 enrolled
Eligibility
All sexes
Timeline
20232029

Study locations (8)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06279741 on ClinicalTrials.gov

Other trials for Bronchopulmonary dysplasia

Additional recruiting or active studies for the same condition.

See all trials for Bronchopulmonary dysplasia

← Back to all trials